Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations.

Kidney Int Rep · 2022 · PMC9263228 · PMID 35812300

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

65 The primary composite kidney outcome did not reach statistical significance (HR 0.62, 95% CI 0.17–2.17).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.